Artigos com autorizações de acesso público - Dean FelsherSaiba mais
GeralNIHHHMIDoDLymphoma Research Foundation, USADFGCancer Research UKCIHRINSERMDamon Runyon Cancer Research FoundationMRCWellcomeGovernment of SpainGovernment of ItalyDOEGatesVACCSNSERCNSFCDBTDSTSwedish Research CouncilBreast Cancer Now, UKFondazione CariploEuropean CommissionCPRITNSFNASAFWFNHMRCFWOFRQSHelmholtzDFFNERCRCNState of CalifoniaSCLKWFV Foundation, USASusan G. Komen
9 artigos não disponíveis publicamente
MYC as a regulator of ribosome biogenesis and protein synthesis
J Van Riggelen, A Yetil, DW Felsher
Nature Reviews Cancer 10 (4), 301-309, 2010
Autorizações: US National Institutes of Health, Canadian Institutes of Health Research
Mitochondrial copper depletion suppresses triple-negative breast cancer in mice
L Cui, AM Gouw, EL LaGory, S Guo, N Attarwala, Y Tang, J Qi, YS Chen, ...
Nature biotechnology 39 (3), 357-367, 2021
Autorizações: US Department of Defense, US National Institutes of Health
KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study
RT Swords, PL Greenberg, AH Wei, S Durrant, AS Advani, MS Hertzberg, ...
Leukemia research 50, 123-131, 2016
Autorizações: US National Institutes of Health
Survival and death signals can predict tumor response to therapy after oncogene inactivation
PT Tran, PK Bendapudi, HJ Lin, P Choi, S Koh, J Chen, G Horng, ...
Science translational medicine 3 (103), 103ra99-103ra99, 2011
Autorizações: US National Institutes of Health, Howard Hughes Medical Institute
Tumor dormancy and oncogene addiction
DW Felsher
Apmis 116 (7‐8), 629-637, 2008
Autorizações: US National Institutes of Health
Reversing cancer from inside and out: oncogene addiction, cellular senescence, and the angiogenic switch
DW Felsher
Lymphatic research and biology 6 (3-4), 149-154, 2008
Autorizações: US National Institutes of Health
Twist1 is required for the development of UVB‐induced squamous cell carcinoma
F Eguiarte‐Solomon, N Blazanin, O Rho, S Carbajal, DW Felsher, ...
Molecular Carcinogenesis 60 (5), 342-353, 2021
Autorizações: Cancer Prevention Research Institute of Texas, USA
Oncogenes and the Initiation and Maintenance of Tumorigenesis
DW Felsher, C Arvanitis, P Bendapudi, P Bachireddy
The Molecular Basis of Human Cancer, 143-157, 2017
Autorizações: US National Institutes of Health, Damon Runyon Cancer Research Foundation
Mathematical modeling of the interactions between cellular programs in response to oncogene inactivation: Incorporation of both cell intrinsic and cell extrinsic (Immune …
C Nwabugwu, K Rakhra, D Felsher, D Paik
2012 IEEE 12th International Conference on Bioinformatics & Bioengineering …, 2012
Autorizações: US National Institutes of Health
117 artigos disponíveis publicamente
MYC regulates the antitumor immune response through CD47 and PD-L1
SC Casey, L Tong, Y Li, R Do, S Walz, KN Fitzgerald, AM Gouw, V Baylot, ...
Science 352 (6282), 227-231, 2016
Autorizações: US National Science Foundation, US Department of Energy, US National …
MYC activation is a hallmark of cancer initiation and maintenance
M Gabay, Y Li, DW Felsher
Cold Spring Harbor perspectives in medicine 4 (6), a014241, 2014
Autorizações: US National Institutes of Health
NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis
C Ma, AH Kesarwala, T Eggert, J Medina-Echeverz, DE Kleiner, P Jin, ...
Nature 531 (7593), 253-257, 2016
Autorizações: US National Institutes of Health, Helmholtz Association, European Commission …
Supramolecular stacking of doxorubicin on carbon nanotubes for in vivo cancer therapy
Z Liu, AC Fan, K Rakhra, S Sherlock, A Goodwin, X Chen, Q Yang, ...
Angewandte Chemie International Edition 48 (41), 7668-7672, 2009
Autorizações: US National Institutes of Health
The MYC oncogene — the grand orchestrator of cancer growth and immune evasion
R Dhanasekaran, A Deutzmann, WD Mahauad-Fernandez, AS Hansen, ...
Nature reviews Clinical oncology 19 (1), 23-36, 2022
Autorizações: US National Institutes of Health, Lymphoma Research Foundation, USA
Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis
Y Xiang, ZE Stine, J Xia, Y Lu, RS O’Connor, BJ Altman, AL Hsieh, ...
The Journal of clinical investigation 125 (6), 2293-2306, 2015
Autorizações: US National Institutes of Health, National Natural Science Foundation of China
Bioorthogonal cyclization-mediated in situ self-assembly of small-molecule probes for imaging caspase activity in vivo
D Ye, AJ Shuhendler, L Cui, L Tong, SS Tee, G Tikhomirov, DW Felsher, ...
Nature chemistry 6 (6), 519-526, 2014
Autorizações: US National Institutes of Health, Susan G. Komen
Cancer prevention and therapy through the modulation of the tumor microenvironment
SC Casey, A Amedei, K Aquilano, AS Azmi, F Benencia, D Bhakta, ...
Seminars in cancer biology 35, S199-S223, 2015
Autorizações: US National Institutes of Health, Cancer Research UK, European Commission …
CD4+ T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation
K Rakhra, P Bachireddy, T Zabuawala, R Zeiser, L Xu, A Kopelman, ...
Cancer cell 18 (5), 485-498, 2010
Autorizações: US National Institutes of Health, Howard Hughes Medical Institute
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead
WH Goodson III, L Lowe, DO Carpenter, M Gilbertson, A Manaf Ali, ...
Carcinogenesis 36 (Suppl_1), S254-S296, 2015
Autorizações: US National Institutes of Health, US Department of Veterans Affairs, Howard …
Designing a broad-spectrum integrative approach for cancer prevention and treatment
KI Block, C Gyllenhaal, L Lowe, A Amedei, ARMR Amin, A Amin, ...
Seminars in cancer biology 35, S276-S304, 2015
Autorizações: US National Institutes of Health, US Department of Veterans Affairs …
As informações de publicação e financiamento são determinadas automaticamente por um programa de computador